Triple therapy with artemether-lumefantrine plus amodiaquine versus artemether-umefantrine alone for artemisinin-resistant, uncomplicated falciparum malaria: an open-label, randomised, multicentre trial (vol 22, pg 867, 2022)

Peto TJ., Tripura R., Callery JJ.

DOI

10.1016/S1473-3099(22)00220-1

Type

Journal

LANCET INFECTIOUS DISEASES

Publication Date

05/2022

Volume

22

Pages

E128 - E128

Permalink Original publication